{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:25:03Z","timestamp":1778070303799,"version":"3.51.4"},"reference-count":56,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,12]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>NUP98::NSD1 is one of the most recurring nucleoporin 98 (NUP98) fusions in acute myeloid leukemia (AML). NUP98::NSD1 positive AML is often associated with adverse outcomes and poor response to conventional treatments. However, limited studies have been done to identify new potential targets to develop better treatment approaches. The C-type lectin domain family 12 member A (CLEC12A) is a cell surface receptor that is differentially expressed in leukemic stem cells compared with healthy hematopoietic stem cells. We found a strong CLEC12A overexpression in both NUP98::NSD1 patients and murine AML cells transformed with the NUP98::NSD1 fusion oncogene. To understand the role of Clec12a in NUP98::NSD1 AML, we depleted Clec12a expression in NUP98::NSD1+NRASG12D-immortalized cells using the CRISPR\/Cas9 approach. NUP98::NSD1+NRASG12D\/Clec12a knockout cells had higher apoptosis levels and lower colony numbers in vitro compared with NUP98::NSD1+NRASG12D\/Clec12a wild-type cells. Importantly, the deletion of Clec12a significantly reduced leukemic engraftment and prolonged survival of the NUP98::NSD1+NRASG12D murine model. Our data suggest to further explore CLEC12A as a potential target for the treatment of NUP98::NSD1 AML.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024015739","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T15:02:16Z","timestamp":1746630136000},"page":"3887-3899","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Clec12a is required for the pathogenesis of NUP98::NSD1 AML"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7935-7798","authenticated-orcid":false,"given":"Sagarajit","family":"Mohanty","sequence":"first","affiliation":[{"name":"1Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany"},{"name":"2Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3941-7497","authenticated-orcid":false,"given":"Fiorella","family":"Charles Cano","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razif","family":"Gabdoulline","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courteney K.","family":"Lai","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basem","family":"Othman","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harish","family":"Sudarsanam","sequence":"additional","affiliation":[{"name":"3Institute of Transfusion Medicine, University Hospital Leipzig, Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Eder","sequence":"additional","affiliation":[{"name":"4Centre for Biological Sciences, University of Veterinary Medicine Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4289-2281","authenticated-orcid":false,"given":"Florian","family":"Grebien","sequence":"additional","affiliation":[{"name":"4Centre for Biological Sciences, University of Veterinary Medicine Vienna, Vienna, Austria"},{"name":"5St. Anna Children's Cancer Research Institute, Vienna, Austria"},{"name":"6CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5081-7869","authenticated-orcid":false,"given":"Daniel B.","family":"Lipka","sequence":"additional","affiliation":[{"name":"7Section of Translational Cancer Epigenomics, Department of Translational Medical Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Henschler","sequence":"additional","affiliation":[{"name":"3Institute of Transfusion Medicine, University Hospital Leipzig, Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5318-9044","authenticated-orcid":false,"given":"Michael","family":"Heuser","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany"},{"name":"8Department of Internal Medicine IV, University Hospital Halle, Martin-Luther-University Halle-Wittenberg, Halle, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"issue":"18","key":"2025081208414014400_bib1","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa074306","article-title":"Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia","volume":"358","author":"Schlenk","year":"2008","journal-title":"N Engl J Med"},{"issue":"7","key":"2025081208414014400_bib2","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1038\/bcj.2016.50","article-title":"Acute myeloid leukemia: a comprehensive review and 2016 update","volume":"6","author":"De Kouchkovsky","year":"2016","journal-title":"Blood Cancer J"},{"issue":"13","key":"2025081208414014400_bib3","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1182\/blood-2011-04-346643","article-title":"NUP98\/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern","volume":"118","author":"Hollink","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2025081208414014400_bib4","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/leu.2012.249","article-title":"Analysis of NUP98\/NSD1 translocations in adult AML and MDS patients","volume":"27","author":"Thol","year":"2013","journal-title":"Leukemia"},{"issue":"4","key":"2025081208414014400_bib5","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1182\/blood.V98.4.1264","article-title":"A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia","volume":"98","author":"Jaju","year":"2001","journal-title":"Blood"},{"issue":"7","key":"2025081208414014400_bib6","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/leu.2016.19","article-title":"Identification of MYC mutations in acute myeloid leukemias with NUP98-NSD1 translocations","volume":"30","author":"Lavallee","year":"2016","journal-title":"Leukemia"},{"issue":"1","key":"2025081208414014400_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/leu.2012.230","article-title":"A rare but specific subset of adult AML patients can be defined by the cytogenetically cryptic NUP98-NSD1 fusion gene","volume":"27","author":"Fasan","year":"2013","journal-title":"Leukemia"},{"issue":"3","key":"2025081208414014400_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/onco3030011","article-title":"NUP98 rearrangements in AML: molecular mechanisms and clinical implications","volume":"3","author":"Mohanty","year":"2023","journal-title":"Onco"},{"issue":"7","key":"2025081208414014400_bib9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/gcc.22064","article-title":"NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia","volume":"52","author":"Shiba","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"2025081208414014400_bib10","doi-asserted-by":"crossref","first-page":"1609128","DOI":"10.1155\/2019\/1609128","article-title":"Mutated WT1, FLT3-ITD, and NUP98-NSD1 fusion in various combinations define a poor prognostic group in pediatric acute myeloid leukemia","volume":"2019","author":"Niktoreh","year":"2019","journal-title":"J Oncol"},{"issue":"11","key":"2025081208414014400_bib11","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"7","key":"2025081208414014400_bib12","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"12","key":"2025081208414014400_bib13","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"10","key":"2025081208414014400_bib14","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.3390\/cancers12102766","article-title":"Targeted inhibition of the NUP98-NSD1 fusion oncogene in acute myeloid leukemia","volume":"12","author":"Mohanty","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2025081208414014400_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.coi.2014.12.002","article-title":"C-type lectins in immunity: recent developments","volume":"32","author":"Dambuza","year":"2015","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"2025081208414014400_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2010.10.005","article-title":"Inhibitory C-type lectin receptors in myeloid cells","volume":"136","author":"Redelinghuys","year":"2011","journal-title":"Immunol Lett"},{"issue":"22","key":"2025081208414014400_bib17","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1158\/0008-5472.CAN-04-1659","article-title":"C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia","volume":"64","author":"Bakker","year":"2004","journal-title":"Cancer Res"},{"issue":"4","key":"2025081208414014400_bib18","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1182\/blood-2005-08-3264","article-title":"Dendritic-cell-associated C-type lectin 2 (DCAL-2) alters dendritic-cell maturation and cytokine production","volume":"107","author":"Chen","year":"2006","journal-title":"Blood"},{"issue":"15","key":"2025081208414014400_bib19","doi-asserted-by":"crossref","first-page":"14792","DOI":"10.1074\/jbc.M313127200","article-title":"Identification and characterization of a novel human myeloid inhibitory C-type lectin-like receptor (MICL) that is predominantly expressed on granulocytes and monocytes","volume":"279","author":"Marshall","year":"2004","journal-title":"J Biol Chem"},{"issue":"4","key":"2025081208414014400_bib20","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1111\/jcmm.13519","article-title":"Mapping the CLEC12A expression on myeloid progenitors in normal bone marrow; implications for understanding CLEC12A-related cancer stem cell biology","volume":"22","author":"Bill","year":"2018","journal-title":"J Cell Mol Med"},{"issue":"7","key":"2025081208414014400_bib21","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1182\/blood-2007-03-083048","article-title":"The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells","volume":"110","author":"van Rhenen","year":"2007","journal-title":"Blood"},{"issue":"8","key":"2025081208414014400_bib22","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1038\/sj.leu.2404754","article-title":"Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission","volume":"21","author":"van Rhenen","year":"2007","journal-title":"Leukemia"},{"issue":"13","key":"2025081208414014400_bib23","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1182\/blood-2005-03-1072","article-title":"Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia","volume":"106","author":"Taussig","year":"2005","journal-title":"Blood"},{"issue":"1","key":"2025081208414014400_bib24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41375-018-0180-3","article-title":"Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML","volume":"33","author":"Haubner","year":"2019","journal-title":"Leukemia"},{"issue":"1","key":"2025081208414014400_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cyto.b.20614","article-title":"Expression of the hMICL in acute myeloid leukemia-a highly reliable disease marker at diagnosis and during follow-up","volume":"82","author":"Larsen","year":"2012","journal-title":"Cytometry B Clin Cytom"},{"issue":"9","key":"2025081208414014400_bib26","doi-asserted-by":"crossref","first-page":"ep8561","DOI":"10.1172\/jci.insight.98561","article-title":"Universal monitoring of minimal residual disease in acute myeloid leukemia","volume":"3","author":"Coustan-Smith","year":"2018","journal-title":"JCI Insight"},{"issue":"2","key":"2025081208414014400_bib27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/leu.2015.252","article-title":"A simple one-tube assay for immunophenotypical quantification of leukemic stem cells in acute myeloid leukemia","volume":"30","author":"Zeijlemaker","year":"2016","journal-title":"Leukemia"},{"issue":"3","key":"2025081208414014400_bib28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/bjh.14270","article-title":"Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome","volume":"175","author":"Toft-Petersen","year":"2016","journal-title":"Br J Haematol"},{"issue":"5","key":"2025081208414014400_bib29","doi-asserted-by":"crossref","first-page":"e0197823","DOI":"10.1371\/journal.pone.0197823","article-title":"Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes","volume":"13","author":"Ostendorf","year":"2018","journal-title":"PLoS One"},{"issue":"22","key":"2025081208414014400_bib30","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1182\/blood.V128.22.766.766","article-title":"Leukemia stem cells are characterized by CLEC12A expression and chemotherapy refractoriness that can be overcome by targeting with chimeric antigen receptor T cells","volume":"128","author":"Kenderian","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2025081208414014400_bib31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/blood.2019003267","article-title":"CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia","volume":"136","author":"Schmoellerl","year":"2020","journal-title":"Blood"},{"issue":"12","key":"2025081208414014400_bib32","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/blood-2006-04-014845","article-title":"High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics","volume":"108","author":"Heuser","year":"2006","journal-title":"Blood"},{"issue":"9","key":"2025081208414014400_bib33","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1101\/gr.135350.111","article-title":"GENCODE: the reference human genome annotation for the ENCODE project","volume":"22","author":"Harrow","year":"2012","journal-title":"Genome Res"},{"issue":"1","key":"2025081208414014400_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"4","key":"2025081208414014400_bib35","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"issue":"3","key":"2025081208414014400_bib36","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nprot.2012.016","article-title":"Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks","volume":"7","author":"Trapnell","year":"2012","journal-title":"Nat Protoc"},{"issue":"2","key":"2025081208414014400_bib37","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq--a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"issue":"12","key":"2025081208414014400_bib38","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"6","key":"2025081208414014400_bib39","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","article-title":"Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity","volume":"176","author":"van Galen","year":"2019","journal-title":"Cell"},{"issue":"2","key":"2025081208414014400_bib40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3324\/haematol.2010.029660","article-title":"Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia","volume":"96","author":"Balgobind","year":"2011","journal-title":"Haematologica"},{"issue":"22","key":"2025081208414014400_bib41","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1101\/gad.306753.117","article-title":"Nup98 recruits the Wdr82-Set1A\/COMPASS complex to promoters to regulate H3K4 trimethylation in hematopoietic progenitor cells","volume":"31","author":"Franks","year":"2017","journal-title":"Genes Dev"},{"issue":"7818","key":"2025081208414014400_bib42","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41586-020-2493-4","article-title":"Expanded encyclopaedias of DNA elements in the human and mouse genomes","volume":"583","author":"Abascal","year":"2020","journal-title":"Nature"},{"issue":"4","key":"2025081208414014400_bib43","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00277-016-2913-6","article-title":"Meis1 is critical to the maintenance of human acute myeloid leukemia cells independent of MLL rearrangements","volume":"96","author":"Liu","year":"2017","journal-title":"Ann Hematol"},{"issue":"22","key":"2025081208414014400_bib44","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1182\/blood.V114.22.1434.1434","article-title":"A potent stimulator of self-renewal in combination with MEIS1 overexpression allows the transformation of late committed myeloid progenitors","volume":"114","author":"Berg","year":"2009","journal-title":"Blood"},{"issue":"3","key":"2025081208414014400_bib45","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.immuni.2013.12.015","article-title":"Clec12a is an inhibitory receptor for uric acid crystals that regulates inflammation in response to cell death","volume":"40","author":"Neumann","year":"2014","journal-title":"Immunity"},{"issue":"1","key":"2025081208414014400_bib46","doi-asserted-by":"crossref","first-page":"37827","DOI":"10.1038\/srep37827","article-title":"CXCR4\/CXCL12 axis counteracts hematopoietic stem cell exhaustion through selective protection against oxidative stress","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"issue":"8","key":"2025081208414014400_bib47","doi-asserted-by":"crossref","first-page":"107684","DOI":"10.1016\/j.celrep.2020.107684","article-title":"CXCR4 signaling has a CXCL12-independent essential role in murine MLL-AF9-driven acute myeloid leukemia","volume":"31","author":"Ramakrishnan","year":"2020","journal-title":"Cell Rep"},{"issue":"1","key":"2025081208414014400_bib48","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1038\/s41598-017-03027-x","article-title":"Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity","volume":"7","author":"Sagar","year":"2017","journal-title":"Sci Rep"},{"key":"2025081208414014400_bib49","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fonc.2018.00389","article-title":"The formin mDia1 regulates acute lymphoblastic leukemia engraftment, migration, and progression in vivo","volume":"8","author":"Thompson","year":"2018","journal-title":"Front Oncol"},{"issue":"1","key":"2025081208414014400_bib50","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1189\/jlb.1A0815-342R","article-title":"Myosin-IIA regulates leukemia engraftment and brain infiltration in a mouse model of acute lymphoblastic leukemia","volume":"100","author":"Wigton","year":"2016","journal-title":"J Leukoc Biol"},{"issue":"1","key":"2025081208414014400_bib51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3324\/haematol.2009.009811","article-title":"Targeting C-type lectin-like molecule-1 for antibody-mediated immunotherapy in acute myeloid leukemia","volume":"95","author":"Zhao","year":"2010","journal-title":"Haematologica"},{"issue":"7","key":"2025081208414014400_bib52","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/14712598.2019.1623200","article-title":"MCLA-117, a CLEC12AxCD3 bispecific antibody targeting a leukaemic stem cell antigen, induces T cell-mediated AML blast lysis","volume":"19","author":"van Loo","year":"2019","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"2025081208414014400_bib53","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1158\/1078-0432.CCR-18-0333","article-title":"An anti-CLL-1 antibody-drug conjugate for the treatment of acute myeloid leukemia","volume":"25","author":"Zheng","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"14","key":"2025081208414014400_bib54","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1182\/bloodadvances.2018020107","article-title":"CLT030, a leukemic stem cell-targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemia","volume":"2","author":"Jiang","year":"2018","journal-title":"Blood Adv"},{"issue":"1","key":"2025081208414014400_bib55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13045-017-0553-5","article-title":"CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia","volume":"11","author":"Wang","year":"2018","journal-title":"J Hematol Oncol"},{"issue":"11","key":"2025081208414014400_bib56","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.3390\/ijms18112259","article-title":"Development of A chimeric antigen receptor targeting C-type lectin-like molecule-1 for human acute myeloid leukemia","volume":"18","author":"Laborda","year":"2017","journal-title":"Int J Mol Sci"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/15\/3887\/2404726\/blooda_adv-2024-015739-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/15\/3887\/2404726\/blooda_adv-2024-015739-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T12:41:54Z","timestamp":1755002514000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/15\/3887\/537149\/Clec12a-is-required-for-the-pathogenesis-of-NUP98"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":56,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025,8,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024015739","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8,12]]},"published":{"date-parts":[[2025,7,29]]}}}